Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen.
the free encyclopedia that anyone can edit. Leucippus was a Greek philosopher of the 5th century BCE. He is credited with founding atomism, with his student Democritus. Leucippus divided the world into two entities: atoms, indivisible particles that make up all things, and the void, the nothingness between the atoms.
Stefano Pessina (2022-present) Website. www .ornellabarra .com. Ornella Barra (born December 1953) is an Italian-born Monegasque businesswoman. [1] A qualified pharmacist, she is chief operating officer, international of Walgreens Boots Alliance. [2] [3] She is married to the Italian billionaire Stefano Pessina. [4] [5]
PharMerica. PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare 's pharmacy business with a subsidiary of AmerisourceBergen. [1] The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida. [2]
2007. Free Cash Flow. $1.5 billion. $859 million. $900 million. $380 million. $710 million. Source: S&P Capital IQ. Now we know how much cash AmerisourceBergen is really pulling in each year.
AmerisourceBergen now expects 2023 adjusted earnings in the range of $11.85 to $11.95 per share, compared with its prior forecast of $11.70 to $11.90 per share. Analysts were expecting an annual ...